Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890025) titled 'CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II Study' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Condition:
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
Intervention:
Biological: MB-CART19.1...
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: December 2026
Target Sample Size: 30
Countries of Recru...